Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TENET HEALTHCARE CORPTHC · Entity 2563 | Director · CEO | August 24, 2026 | August 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TENET HEALTHCARE CORP
Report date August 24, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 433,564 |
Ending reported balance
After 2026-08-25 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-08-24 · Sale · Disposed 13,344 · Balance 520,220 F1: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $277.58 to $278.57. F2: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Row 2 · 2026-08-24 · Sale · Disposed 36,656 · Balance 483,564 F2: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $278.59 to $279.14. Row 3 · 2026-08-25 · Sale · Disposed 17,220 · Balance 466,344 F2: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F4: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $272.65 to $273.64. Row 4 · 2026-08-25 · Sale · Disposed 24,881 · Balance 441,463 F2: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F5: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $273.65 to $274.64. Row 5 · 2026-08-25 · Sale · Disposed 7,899 · Balance 433,564 F2: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F6: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $274.73 to $275.55. |
Filing footnotes · ownership attribution and instrument terms
F1: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $277.58 to $278.57.
F2: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $278.59 to $279.14.
F4: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $272.65 to $273.64.
F5: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $273.65 to $274.64.
F6: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $274.73 to $275.55.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2026 Filed Aug 27, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 7,899 | $275.26 | $2,174,278.74 |
DisclosureSEC source: 0001193125-26-369162 · ownership.xml · nonDerivative · entry 5 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 433,564 F2 · price: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F6 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $274.73 to $275.55. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 24,881 | $274.10 | $6,819,882.10 |
DisclosureSEC source: 0001193125-26-369162 · ownership.xml · nonDerivative · entry 4 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 441,463 F2 · price: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F5 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $273.65 to $274.64. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 17,220 | $273.34 | $4,706,914.80 |
DisclosureSEC source: 0001193125-26-369162 · ownership.xml · nonDerivative · entry 3 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 466,344 F2 · price: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F4 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $272.65 to $273.64. Read SEC document |
| August 24, 2026 Filed Aug 27, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 36,656 | $278.90 | $10,223,358.40 |
DisclosureSEC source: 0001193125-26-369162 · ownership.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 483,564 F2 · price: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $278.59 to $279.14. Read SEC document |
| August 24, 2026 Filed Aug 27, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 13,344 | $278.17 | $3,711,900.48 |
DisclosureSEC source: 0001193125-26-369162 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 520,220 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $277.58 to $278.57. F2 · price: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:01 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2023 March Restricted Stock Units · Derivative | 36,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-089422 · ownership.xml · derivative · entry 8 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,384 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 27, 2026 (the business day prior to March 1, 2026, which fell on a weekend). F9 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 27, 2026 (the business day prior to March 1, 2026, which fell on a weekend). F9 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 27, 2026 (the business day prior to March 1, 2026, which fell on a weekend). F8 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:01 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2024 February Restricted Stock Units · Derivative | 22,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-089422 · ownership.xml · derivative · entry 7 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,417 Underlying: Common Stock · 22,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 28, 2024, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 27, 2026 (the business day prior to February 28, 2026, which fell on a weekend). F7 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 28, 2024, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 27, 2026 (the business day prior to February 28, 2026, which fell on a weekend). F7 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 28, 2024, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 27, 2026 (the business day prior to February 28, 2026, which fell on a weekend). F8 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:01 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2026 February Restricted Stock Units · Derivative | 36,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-089422 · ownership.xml · derivative · entry 6 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,092 Underlying: Common Stock · 36,092 shares Expires not disclosed F6 · derivative.exercise_price: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F6 · derivative.exercise_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F6 · derivative.expiration_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:01 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 124,959 | $239.39 | $29,913,935.01 |
DisclosureSEC source: 0001193125-26-089422 · ownership.xml · nonDerivative · entry 5 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 533,564 F2 · shares: Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units. F5 · price: Represents the closing price of the common stock of the Issuer on February 27, 2026. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:01 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 29,919 | $239.39 | $7,162,309.41 |
DisclosureSEC source: 0001193125-26-089422 · ownership.xml · nonDerivative · entry 4 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 658,523 F4 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F5 · price: Represents the closing price of the common stock of the Issuer on February 27, 2026. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:01 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 9,282 | $237.58 | $2,205,217.56 |
DisclosureSEC source: 0001193125-26-089422 · ownership.xml · nonDerivative · entry 3 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 688,442 F2 · shares: Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units. F3 · price: Represents the closing price of the common stock of the Issuer on the vesting date for the award. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:01 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 36,384 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-089422 · ownership.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 697,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:01 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 22,417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-089422 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 661,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 24, 2026 Filed Feb 27, 2026 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2025 Restricted Stock Units · Derivative | 18,242 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-078289 · ownership.xml · derivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,486 Underlying: Common Stock · 18,242 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2025, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 24, 2026. F2 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2025, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 24, 2026. F2 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2025, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 24, 2026. F3 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 24, 2026 Filed Feb 27, 2026 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 18,242 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-078289 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 638,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 245,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-055526 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 620,681 F1 · kind: Represents a grant of performance-based restricted stock that was earned on the date the Human Resources Committee of the Company certified the achievement of the applicable performance targets based on the extent to which the applicable performance goals were attained for the performance period of January 1, 2023 to December 31, 2025. Read SEC document |
| December 31, 2025 Filed Jan 3, 2026 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2025 January Restricted Stock Units · Derivative | 13,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-001194 · ownership.xml · derivative · entry 3 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,049 Underlying: Common Stock · 13,016 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The restricted stock units were granted on January 23, 2025, pursuant to the 2019 Stock Incentive Plan, vest equally in 1/4 increments on December 31, 2025, 2026, 2027 and 2028, and the first 1/4 increment vested on December 31, 2025. F4 · derivative.exercise_date: The restricted stock units were granted on January 23, 2025, pursuant to the 2019 Stock Incentive Plan, vest equally in 1/4 increments on December 31, 2025, 2026, 2027 and 2028, and the first 1/4 increment vested on December 31, 2025. F4 · derivative.expiration_date: The restricted stock units were granted on January 23, 2025, pursuant to the 2019 Stock Incentive Plan, vest equally in 1/4 increments on December 31, 2025, 2026, 2027 and 2028, and the first 1/4 increment vested on December 31, 2025. F5 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| December 31, 2025 Filed Jan 3, 2026 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 6,610 | $198.72 | $1,313,539.20 |
DisclosureSEC source: 0001193125-26-001194 · ownership.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375,089 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F3 · price: Represents the closing price of the common stock of the Issuer on December 31, 2025. Read SEC document |
| December 31, 2025 Filed Jan 3, 2026 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 13,016 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-001194 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| September 10, 2025 Filed Sep 13, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 19,306 | $191.70 | $3,700,960.20 |
DisclosureSEC source: 0001760857-25-000007 · ownership.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,683 F2 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $191.18 to $192.06. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 10, 2025 Filed Sep 13, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 59,456 | $190.48 | $11,325,178.88 |
DisclosureSEC source: 0001760857-25-000007 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 387,989 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $190.14 to $191.05. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2021 September Restricted Stock Units · Derivative | 53,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001760857-25-000005 · ownership.xml · derivative · entry 4 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,341 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The restricted stock units were granted on September 1, 2021, pursuant to the 2019 Stock Incentive Plan and vested in full on August 29, 2025 (the business day prior to September 1, 2025, which fell on a federal holiday). F5 · derivative.exercise_date: The restricted stock units were granted on September 1, 2021, pursuant to the 2019 Stock Incentive Plan and vested in full on August 29, 2025 (the business day prior to September 1, 2025, which fell on a federal holiday). F5 · derivative.expiration_date: The restricted stock units were granted on September 1, 2021, pursuant to the 2019 Stock Incentive Plan and vested in full on August 29, 2025 (the business day prior to September 1, 2025, which fell on a federal holiday). F6 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 54,174 | $184.33 | $9,985,893.42 |
DisclosureSEC source: 0001760857-25-000005 · ownership.xml · nonDerivative · entry 3 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 447,445 F4 · shares: Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units. F3 · price: Represents the closing price of the common stock of the Issuer on September 29, 2025. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 27,087 | $184.33 | $4,992,946.71 |
DisclosureSEC source: 0001760857-25-000005 · ownership.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 501,619 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F3 · price: Represents the closing price of the common stock of the Issuer on September 29, 2025. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 53,341 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001760857-25-000005 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 528,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 13, 2025 Filed Aug 16, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 106,682 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-109515 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 475,365 F1 · kind: Represents a grant of performance-based restricted stock that was earned on the date the Human Resources Committee of the Company certified the achievement of the applicable performance targets based on the extent to which the applicable performance goals were attained for the performance period of January 1, 2021 to June 30, 2025. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 31,076 | $126.59 | $3,933,910.84 |
DisclosureSEC source: 0000950170-25-032672 · ownership.xml · nonDerivative · entry 3 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,683 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F3 · price: Represents the closing price of the common stock of the Issuer on February 28, 2025. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2023 March Restricted Stock Units · Derivative | 36,384 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032672 · ownership.xml · derivative · entry 5 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,384 Underlying: Common Stock · 36,384 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 28, 2025 (the business day prior to March 1, 2025, which fell on a weekend). F6 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 28, 2025 (the business day prior to March 1, 2025, which fell on a weekend). F6 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 28, 2025 (the business day prior to March 1, 2025, which fell on a weekend). F5 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2024 February Restricted Stock Units · Derivative | 22,416 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032672 · ownership.xml · derivative · entry 4 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,834 Underlying: Common Stock · 22,416 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 28, 2024, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 28, 2025. F4 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 28, 2024, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 28, 2025. F4 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 28, 2024, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 28, 2025. F5 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 36,384 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-032672 · ownership.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 22,416 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-032672 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 23:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2025 February Restricted Stock Units · Derivative | 54,728 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028023 · ownership.xml · derivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,728 Underlying: Common Stock · 54,728 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2022 Restricted Stock Units · Derivative | 21,066 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-027082 · ownership.xml · derivative · entry 4 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,066 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 21, 2025, (the business day prior to February 23, 2025, which fell on a weekend). F5 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 21, 2025, (the business day prior to February 23, 2025, which fell on a weekend). F5 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 21, 2025, (the business day prior to February 23, 2025, which fell on a weekend). F6 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 66,697 | $129.60 | $8,643,931.20 |
DisclosureSEC source: 0000950170-25-027082 · ownership.xml · nonDerivative · entry 3 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,959 F4 · shares: Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units. F3 · price: Represents the closing price of the common stock of the Issuer on February 21, 2025. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 11,134 | $129.60 | $1,442,966.40 |
DisclosureSEC source: 0000950170-25-027082 · ownership.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 407,656 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F3 · price: Represents the closing price of the common stock of the Issuer on February 21, 2025. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 21,066 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-027082 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 418,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 23:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 126,203 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-020093 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 397,724 F1 · kind: Represents a grant of performance-based restricted stock that was earned on the date the Human Resources Committee of the Company certified the achievement of the applicable performance targets based on the extent to which the applicable performance goals were attained for the performance period of January 1, 2022 to December 31, 2024. Read SEC document |
| January 23, 2025 Filed Jan 25, 2025 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2025 January Restricted Stock Units · Derivative | 52,065 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008959 · ownership.xml · derivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,065 Underlying: Common Stock · 52,065 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest prorata annually in four substantially equal installments on December 31, 2025, 2026, 2027 and 2028 F1 · derivative.exercise_date: These time-based restricted stock units vest prorata annually in four substantially equal installments on December 31, 2025, 2026, 2027 and 2028 F1 · derivative.expiration_date: These time-based restricted stock units vest prorata annually in four substantially equal installments on December 31, 2025, 2026, 2027 and 2028 Read SEC document |
| August 15, 2024 Filed Aug 17, 2024 00:30 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 1,532 | $155.36 | $238,011.52 |
DisclosureSEC source: 0000950170-24-098237 · ownership.xml · nonDerivative · entry 4 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 0 F2 · price: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F4 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $155.00 to $155.96. Read SEC document |
| August 15, 2024 Filed Aug 17, 2024 00:30 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 12,241 | $154.50 | $1,891,234.50 |
DisclosureSEC source: 0000950170-24-098237 · ownership.xml · nonDerivative · entry 3 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 1,532 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $154.00 to $154.99. F2 · price: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 14, 2024 Filed Aug 17, 2024 00:30 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 5,129 | $155.40 | $797,046.60 |
DisclosureSEC source: 0000950170-24-098237 · ownership.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 13,773 F2 · price: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $155.00 to $155.72. Read SEC document |
| August 14, 2024 Filed Aug 17, 2024 00:30 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 81,098 | $154.35 | $12,517,476.30 |
DisclosureSEC source: 0000950170-24-098237 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 18,902 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $154.00 to $154.99. F2 · price: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 10, 2024 Filed Jun 13, 2024 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GiftCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-072623 · ownership.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Wife Disclosed balance after: 100,000 F1 · kind: Represents transfer of shares to wife of reporting person. F1 · balance_after: Represents transfer of shares to wife of reporting person. Read SEC document |
| June 10, 2024 Filed Jun 13, 2024 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GiftCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-072623 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,521 F1 · kind: Represents transfer of shares to wife of reporting person. F1 · balance_after: Represents transfer of shares to wife of reporting person. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:30 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GiftCommon Stock | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-042384 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,521 F1 · kind: Gift of securities by the reporting person to an irrevocable trust, with an independent trustee, for the benefit of his wife and children. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2023 March Restricted Stock Units · Derivative | 36,384 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026604 · ownership.xml · derivative · entry 3 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,768 Underlying: Common Stock · 36,384 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second, and third anniversaries of the grant date, and the first 1/3 increment vested on March 1, 2024. F3 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second, and third anniversaries of the grant date, and the first 1/3 increment vested on March 1, 2024. F3 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second, and third anniversaries of the grant date, and the first 1/3 increment vested on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 18,440 | $94.29 | $1,738,707.60 |
DisclosureSEC source: 0000950170-24-026604 · ownership.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 496,521 F4 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F2 · price: Represents the closing price of the common stock of the Issuer on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 36,384 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-026604 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 514,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2024 February Restricted Stock Units · Derivative | 67,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024242 · ownership.xml · derivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,250 Underlying: Common Stock · 67,250 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| February 24, 2024 Filed Feb 28, 2024 01:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2021 Restricted Stock Units · Derivative | 25,229 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-021570 · ownership.xml · derivative · entry 7 Sutaria Saumya · CIK 0001760857 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,229 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 24, 2024. F5 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 24, 2024. F5 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 24, 2024. F6 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.